Nedd4 ubiquitylates VDAC2/3 to suppress erastin-induced ferroptosis in melanoma.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 31974380.
- Also identified by DOI 10.1038/s41467-020-14324-x and PMC identifier 6978386.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Ferroptosis is a newly defined form of regulated cell death characterized by the iron-dependent accumulation of lipid hydroperoxides. Erastin, the ferroptosis activator, binds to voltage-dependent anion channels VDAC2 and VDCA3, but treatment with erastin can result in the degradation of the channels. Here, the authors show that Nedd4 is induced following erastin treatment, which leads to the ubiquitination and subsequent degradation of the channels. Depletion of Nedd4 limits the protein degradation of VDAC2/3, which increases the sensitivity of cancer cells to erastin. By understanding the molecular mechanism of erastin-induced cellular resistance, we can discover how cells adapt to new molecules to maintain homeostasis. Furthermore, erastin-induced resistance mediated by FOXM1-Nedd4-VDAC2/3 negative feedback loop provides an initial framework for creating avenues to overcome the drug resistance of ferroptosis activators.
Medical subject headings
- Antineoplastic Agents
- Melanoma
- Mitochondrial Membrane Transport Proteins
- Nedd4 Ubiquitin Protein Ligases
- Piperazines
- Voltage-Dependent Anion Channel 2
- Voltage-Dependent Anion Channels